Avoiding Immigration Pitfalls in Cross-Company Collaboration

Aug 25, 2021 | Human Resources Services

Cross-organizational collaboration in the Life Sciences industry is a staple for breakthrough innovation and scaling product distribution.  Working together brings exciting opportunities to address and build new solutions that provide greater impact, reach, and shared profitability.

Successful collaboration was perhaps at its strongest during the development of Covid-19 vaccines. The challenges of the pandemic brought together experts from across the pharma industry, government, and academia. The collaborative efforts culminated in the development of therapies and diagnostics at a highly expedited pace. Without these global partnerships, timelines would have stretched, and success may have been more elusive.

From a staffing perspective, it is not uncommon for employees with specific skillsets to be temporarily contracted out to a partner company.  This can raise challenges, however, as current travel policies, visa conditions, and immigration restrictions can make that arrangement complicated for foreign-born workers.

Typically, foreign-born workers are authorized to perform a specific job for a specific employer – any roles outside of the visa parameters may require additional authorizations. To increase the flexibility and utility of the global workforce, Life Sciences leaders and HR professionals should know the options available to them.

Partnering and collaborating within the Life Sciences industry is essential for increased innovation; HR can and should empower that mission. At WR, we work with both HR professionals and foreign-born employees to help ensure that you, your company, and your employees find the right immigration solution to advance your goals. 

Subscribe to the WR Immigration Newsletters

Start the RFP Process

Join the Corporate Benchmarking Roundtable

Request an Attorney Consultation

Related Posts:

New $1,000 Parole Fee Announced; AOS Advance Parole Exempt

Effective October 16, 2025, the Department of Homeland Security (DHS) will begin imposing a $1,000 fee for individuals granted parole under INA §212(d)(5)(A). This new fee applies to most parole grants, including parole-in-place, re-parole, and humanitarian parole, but does not apply to employees re-entering the U.S. on Advance Parole tied...

DE&I at Biotech Week: Creating a Path for Foreign-Born Workers

We proudly sponsored Biotech Week Boston’s Diversity Equity & Inclusion (DE&I) Summit last week.  The Summit brought together panelists and attendees from over 22 countries around the world, each with a diverse set of experiences, perspectives, and important themes to add to the conversation.   WR Immigration’s Julie Galvin led a session focused on overcoming common obstacles, including incorporating a DE&I lens when hiring foreign-born employees.  ...